Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-04-14
• Last 15 days FTD volume: S$1.55 M
• Last 3 months FTD volume: S$33.09 M
• Last 12 months FTD volume: S$0.12 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	S$88.29 M	S$0.17 B	🇺🇸 USA
Pfizer PFE	S$52.65 M	S$0.14 B	🇺🇸 USA
AbbVie ABBV	S$0.18 B	S$0.25 B	🇺🇸 USA
Eli Lilly LLY	S$33.48 M	S$0.40 B	🇺🇸 USA
Amgen AMGN	S$0.19 B	S$0.42 B	🇺🇸 USA
Biogen BIIB	S$5.65 M	S$56.85 M	🇺🇸 USA
Illumina ILMN	S$13.38 M	S$25.5 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	S$52.43 M	S$0.13 B	🇺🇸 USA
Merck MRK	S$0.11 B	S$0.19 B	🇺🇸 USA